Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. - Wikidata - awgldk - TriplyDB

Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.

Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.

http://www.wikidata.org/entity/Q44432097

about

Genetic alteration and gene expression modulation during cancer progression Internet-based Profiler system as integrative framework to support translational research.One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling DAB2IP in cancer Proteomics of breast cancer: principles and potential clinical applications.Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer Differential CARM1 expression in prostate and colorectal cancers.Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling.Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.Cell and gene therapy for severe heart failure patients: the time and place for Pim-1 kinase.Proteomics in prostate cancer biomarker discovery.Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells Prognostic factors in prostate cancer.Schizophrenia proteomics: biomarkers on the path to laboratory medicine?p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.Expression of pim-1 in tumors, tumor stroma and tumor-adjacent mucosa co-determines the prognosis of colon cancer patients.Defining aggressive prostate cancer using a 12-gene model.Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.DOC-2/DAB2 interacting protein status in high-risk prostate cancer correlates with outcome for patients treated with radiation therapy.Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy Genes differentially expressed in prostate cancer.Tissue microarrays in urology.Connections between epigenetic gene silencing and human disease.Genetic and epigenetic changes in human prostate cancer Aromatic amines and biomarkers of human exposure.Tissue microarrays: fast-tracking protein expression at the cellular level.Prognostic and predictive markers in canine tumours: rationale and relevance. A review.EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR Evaluation of HOXB13 as a molecular marker of recurrent prostate cancer Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.Construction of tissue microarrays from prostate needle biopsy specimens.Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer.Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma.Epigenetic targets in the diagnosis and treatment of prostate cancer.The ratio of matrix metalloproteinase to E-cadherin expression: a pilot study to assess mRNA and protein expression among African American prostate cancer patients Genomic signatures associated with the development, progression, and outcome of prostate cancer.Chromatin, cancer and drug therapies.Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapy

P2860

Q24798750-2AFD9466-125E-4E5C-819B-C6B4F788BCDA Q25257221-8A4C1A1B-EC1D-46CD-BD2F-A7926CDBE5DD Q26740548-78424BB1-FC8C-4F00-80B6-044D5A29FF9B Q26776456-70273CC1-3887-4599-B687-38535C107401 Q33245053-8B2DE22F-E805-4EFF-9A80-3D7B38CAC7BD Q33352317-B351B53D-6625-45D5-8775-85F07FE10E45 Q33576367-DA876237-8353-4924-B8CC-88172C398750 Q33766326-1B7283CB-1D68-40A5-B257-4294DD74D034 Q33933887-80F60535-317C-48EF-9378-91FCEC30A244 Q33940135-05CFDF70-065B-4D9A-8595-0033EF756E2F Q34075071-BA1FF214-F3BB-45D7-B983-BC5506D35F1A Q34096086-C98C24D5-E85E-49D2-9356-2DE4967EFF2C Q34409667-9FD166B3-FBED-4EA5-8142-B44920C27F35 Q34619655-DF362891-9255-4E5F-B57D-5D31C45AA348 Q34682069-310AE9F7-50FC-4F17-997A-38C7DB3C6ABA Q34973585-EE6BA0E9-2DE3-44E4-A560-D3C0D65A4F60 Q34997026-AFC91B3F-C9AF-4E6C-921E-91CBE76B2F81 Q35014814-DBD1270C-87ED-45A6-AF24-8AF762419E06 Q35060298-3E6CBAB4-835C-46B2-AAEC-88F4E8A8B726 Q35141481-2091B4F8-941B-4A12-BEE5-EAAA900388D2 Q35729485-C9C76948-FBC6-40FE-8E47-87D04BD13293 Q35751889-8F4F8B10-FEDE-4AC1-8822-76ADEE5CFA59 Q35772604-A5F8C229-783E-4925-998E-7A9EF26BBF8F Q35817170-BC710DDB-E227-4890-B18E-A058AB0722D1 Q35843804-2B09A85E-9ED8-4594-AB39-7A32EE58B6C2 Q36022274-E0B1199F-77A8-498A-BC25-B61A154A1225 Q36104064-8A6A6B37-32F3-451B-B676-78CC13B2B822 Q36168371-956BBFFF-56E2-41DB-8DB9-2DD63399C124 Q36196363-75EB2B24-0DA8-47DB-A06B-13E4B8BBA765 Q36365753-91F815B5-E5D2-44A9-B81C-665284CAE3DC Q36383272-8BAD8221-DAB5-4560-99C9-10C57802ECFF Q36439622-3AEB7E85-4A9C-4D36-8697-A08D3C30E305 Q36615192-16783B1E-71DB-4F4F-846F-C6C10C8743AB Q36615956-FA16BD99-D6CD-414E-BC3D-F21003935B6B Q36616798-495EEBCA-EF2D-4B15-98DD-CE38DFBEBA7B Q36750234-563415F5-11DA-4E58-87A7-89EF7FA5521C Q36951975-B5D11D6F-C026-430B-8ED8-636127BE7D42 Q37031510-8AEC3983-6179-4894-B2AD-705F84567A8A Q37073231-DEA9EA9B-D7A3-4B70-9847-3D9867849EB8 Q37084855-D71A5A95-0036-440A-9698-233CEC80D32B

P2860

Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.

http://www.wikidata.org/entity/Q44432097

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Multiplex biomarker approach f ...... recurrence of prostate cancer.

@en

Multiplex biomarker approach f ...... recurrence of prostate cancer.

@nl

type

label

Multiplex biomarker approach f ...... recurrence of prostate cancer.

@en

Multiplex biomarker approach f ...... recurrence of prostate cancer.

@nl

prefLabel

Multiplex biomarker approach f ...... recurrence of prostate cancer.

@en

Multiplex biomarker approach f ...... recurrence of prostate cancer.

@nl

P1433

Q44432097-69CB7C1C-CBA7-4953-B1F1-AA1017B86A9B

P1476

Q44432097-6693CC40-DE34-4730-96B5-608DC0B74820

P2093

Q44432097-11DD9064-C019-43D8-9200-F2DBAD2A4156

Q44432097-3815E92F-78F3-4B14-B8A7-EABB001C964C

Q44432097-6A7460F7-611B-42F1-8067-29AAF33FF258

Q44432097-AA5E8587-F596-4B8D-B149-28B2F380FD5A

Q44432097-ACA59718-BE14-428A-B551-0FA0ED8C2E09

P304

Q44432097-269C82B7-5C4B-4DB9-BEBB-852B41D5870B

P31

Q44432097-0A835702-FF5A-4653-8747-7A06A8897308

P356

Q44432097-5EA2F815-415F-4056-A477-952471E1258C

P407

Q44432097-D66D840A-53A2-426A-972C-821BD29162EC

P433

Q44432097-93D7F223-522C-4CFE-B697-506070079BB6

P478

Q44432097-FDEED52B-19E4-4E5B-9154-45671508D4B7

P577

Q44432097-055C6DD9-CFA7-432D-A147-D90E578FD581

P5875

Q44432097-BFE0090B-15F4-4C9E-9B88-FF38F82F822F

P698

Q44432097-0EEC5FB0-AA30-4475-9772-A3EE25BBF646

P921

Q44432097-BA2CE612-B29B-4424-9295-DE5E3B7760F2

P356

P1433

Journal of the National Cancer Institute

P1476

Multiplex biomarker approach f ...... recurrence of prostate cancer.

@en

P2093

Arie P Otte

http://www.w3.org/2001/XMLSchema#string

Arul M Chinnaiyan

http://www.w3.org/2001/XMLSchema#string

Daniel R Rhodes

http://www.w3.org/2001/XMLSchema#string

Mark A Rubin

http://www.w3.org/2001/XMLSchema#string

Martin G Sanda

http://www.w3.org/2001/XMLSchema#string

P304

661-668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/95.9.661

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10771913

http://www.w3.org/2001/XMLSchema#string

P698

12734317

http://www.w3.org/2001/XMLSchema#string

P921